Xpert Xpress Flu/RSV, Xpert Nasopharyngeal Sample Collection Kit, GeneXpert Dx Systems (GX-I, GX-II, GX-IV, GX-XVI), GeneXpert Infinity-48 System and GeneXpert Infinity-48s System, GeneXpert Infinity-80 System
Respiratory Virus Panel Nucleic Acid Assay System. 510(k) K162331, from Cepheid (Sunnyvale, CA). Product code OCC, class 2.
As of Nov 20, 2026, K162331 is an FDA 510(k) held by Cepheid, substantially equivalent on Feb 9, 2017 after 174 days, with no recalls tied to it in FDA's recall database.
- Review time: 174 days
- Recalls: 0
- Xpert Flu/Rsv XC AssayK142045 · Cepheid · Nov 22, 2014
- Xpert Flu+RSV Xpress, Xpert Nasopharyngeal Sample Collection Kit, GeneXpert Xpress System (GX-I)K151226 · Cepheid · Dec 3, 2015
- SimplicityDx Panel FluA/FluB/RSVK262789 · Molecular Designs · Nov 4, 2026
- ID NOW Influenza A & B 2; ID NOW RSV; ID NOW Strep A 2; ID NOW COVID-19 2.0K262747 · Abbott Diagnostics Scarborough, Inc. · Aug 31, 2026
- BioCode® Respiratory Pathogen Panel (RPP)K254139 · Applied BioCode, Inc. · May 1, 2026
- NxTAG® Respiratory Pathogen PanelK242613 · Luminex Molecular Diagnostics, Inc. · Oct 2, 2024
- ID NOW Influenza A & B 2K232775 · Abbott Diagnostics Scarborough, Inc. · Oct 10, 2023
- Panther Fusion AdV/hMPV/RV AssayK231017 · Hologic, Inc. · May 5, 2023
- cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat SystemK213822 · Roche Molecular Systems, Inc. · Jul 6, 2022
- cobas Influenza A/B & RSV Nucleic acid test for use on the cobas Liat SystemK210234 · Roche Molecular Systems, Inc. · Feb 16, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 19, 2016
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3980
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files